Panadol costs more now. What has this meant for the pharma industry?
Haleon has benefited from the new drug pricing policy introduced by DRAP and it shows in its financial results
DRAP orders urgent recall of substandard medicines, medical products
Contaminated injections, syrups, and IV cannulas flagged; crackdown launched nationwide
Citi Pharma completes first export to MENA region, targets EUR 10 million in annual global sales
Finalizes EUR 560,000 shipment; aims to expand exports to North America and beyond
Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi
Investigation launched against two pharmaceutical companies over illegal drug trade
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
Citi Pharma ventures into direct marketing sector
Company aims to improve medicine accessibility and expand globally
Citi Pharma partners with Mersi Farma to establish advanced API plants in Indonesia
Collaboration to bolster pharmaceutical production and expand nutraceutical market
Despite deregulated prices, Searle swings to a loss
Price increases were not enough to compensate for increases in operating costs, despite a gross profit margin expansion
Drug price deregulation has come to Pakistan. What will this mean?
Companies can finally raise prices, which is likely to result in higher prices, but also likely to mean fewer shortages of essential drugs
Citi Pharma enters into joint venture to establish API, formulation facility in Saudi Arabia
Joint venture will focus on manufacturing essential APIs and formulation products to meet the healthcare needs of the KSA and the broader MENA region
Ferozsons strikes deal with Gilead Sciences to produce generic HIV drugÂ
Ferozsons or its affiliates can manufacture and sell lenacapavir in 120 countriesÂ
BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead?Â
The pharma company, which has been exporting to countries like Indonesia, Belarus and Ukraine, saw book building at Rs 77/share and oversubscription of 3.4 times.
Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
PPMA strongly refutes allegations against quality of Pakistani medicines
Pharmaceutical body defends industry standards, warns against harmful impact on exports and national reputation